Handelsbanken Fonder Ab Biogen Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Biogen Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 68,502 shares of BIIB stock, worth $11.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

68,502

Previous 67,206 1.93%

Holding current value

$11.9 Million

Previous $15.6 Million 14.78%

% of portfolio

0.05%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$189.07 - $236.8 $245,034 - $306,892	1,296 Added 1.93%	68,502 $13.3 Million
Q2 2024 Aug 05, 2024	BUY	$190.52 - $236.72 $599,375 - $744,721	3,146 Added 4.91%	67,206 $15.6 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $1.38 Million - $1.75 Million	6,527 Added 11.34%	64,060 $13.8 Million
Q4 2023 Feb 01, 2024	SELL	$222.59 - $267.94 $4.06 Million - $4.88 Million	-18,231 Reduced 24.06%	57,533 $14.9 Million
Q3 2023 Oct 19, 2023	BUY	$253.3 - $285.89 $246,714 - $278,456	974 Added 1.3%	75,764 $19.5 Million
Q2 2023 Aug 02, 2023	BUY	$275.25 - $318.06 $1.53 Million - $1.77 Million	5,555 Added 8.02%	74,790 $21.3 Million
Q1 2023 Apr 28, 2023	BUY	$256.56 - $292.34 $773,015 - $880,820	3,013 Added 4.55%	69,235 $19.2 Million
Q4 2022 Feb 07, 2023	SELL	$252.44 - $306.72 $3.07 Million - $3.73 Million	-12,177 Reduced 15.53%	66,222 $18.3 Million
Q3 2022 Oct 27, 2022	SELL	$194.69 - $268.46 $308,778 - $425,777	-1,586 Reduced 1.98%	78,399 $20.9 Million
Q2 2022 Aug 03, 2022	BUY	$187.54 - $223.02 $7.06 Million - $8.4 Million	37,671 Added 89.03%	79,985 $16.3 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $4.53 Million - $5.71 Million	-23,372 Reduced 35.58%	42,314 $8.91 Million
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $4.9 Million - $6.3 Million	-21,897 Reduced 25.0%	65,686 $15.8 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $2.48 Million - $3.23 Million	-8,757 Reduced 9.09%	87,583 $24.8 Million
Q2 2021 Aug 03, 2021	BUY	$259.0 - $414.71 $2.37 Million - $3.79 Million	9,134 Added 10.47%	96,340 $33.4 Million
Q1 2021 Apr 29, 2021	BUY	$242.95 - $284.63 $6.2 Million - $7.27 Million	25,525 Added 41.38%	87,206 $24.4 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $637,429 - $959,489	-2,698 Reduced 4.19%	61,681 $15.1 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $223,465 - $258,019	-844 Reduced 1.29%	64,379 $18.3 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $6.69 Million - $8.86 Million	25,851 Added 65.66%	65,223 $17.5 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $1.21 Million - $1.53 Million	-4,500 Reduced 10.26%	39,372 $12.5 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $9.65 Million - $13.3 Million	43,872 New	43,872 $13 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Biogen Inc. Transaction History